Tuberculosis
The Union - North American Region Meeting
2009 Meeting Archives
The BC Lung Association serves as the Meeting Secretariat for the Union Against Tuberculosis and Lung Disease (IUATLD or ‘the Union’) - North American Region.
The 2009 Meeting of the Union - North American Region took place in Vancouver, Canada, February 26 to 28, 2009.
Find copies of speaker presentations below. Should you have questions or concerns please call Dr. Menn Biagtan at 604.731.5864 or email biagtan@bc.lung.ca.
Download PDFs
FEBRUARY 26, 2009:
STOP TB Meeting
Examining the Challenges to Reach All TB Patients: DOTS Expansion?
Dr. Leopold Blanc, WHO, Geneva, Switzerland
Best Practices in Engaging Communities: The Poverty Dimension in TB Control
Dr. S. Bertel Squire, Liverpool School of Tropical Medicine, Liverpool, UK
South Africa/University of Ottawa Partnership for TB/HIV Clinical Care
Dr. Gonzalo Alvarez, University of Ottawa at the Ottawa Hospital, Ottawa, ON, Canada
CDC Partnerships in TB Control in Africa
Dr. Eugene McCray, CDC, Atlanta, GA, USA
Nursing Assembly
Social Initiatives Necessary to Achieving the 2015 TB Elimination Goal: Utilizing Critical Incident Technique
Ms. Claire Murphy, Boston University School of Medicine, Boston, MA, USA
Combating Tuberculosis for Homeless Population in Downtown Eastside
Mr. Jerry Cyr, BCCDC/TB Control, Vancouver, BC, Canada
Reaching Out to the Marginalized Homeless
Ms. Liz Evans, PHS Community Services Society, Vancouver, BC, Canada
Public Health Interventions to Reduce TB Risk in the Homeless Populations
Ms. Marcia Stone, Healthcare for the Homeless Network, King County, Seattle, USA
SCRAP-TB: An Aboriginal Community Capacity Building Process
Ms. Shawna Buchholz, BCCDC, Vancouver, BC, Canada
TB Outbreak Experience in British Columbia
Ms. Shelley Dean, BCCDC/TB Control, Vancouver, BC, Canada
General Session
Beyond TB Lecture - Tuberculosis & Tobacco: Why We Should Act Together
Dr. Doug Bettcher, WHO, Geneva, Switzerland
FEBRUARY 27, 2009:
Morning Session
Controversies in the Diagnosis and Treatment of Drug Resistant TB
Dr. Joanne Julien, SNTC/University of Florida, Gainesville, FL, USA
Prevention and Infection Control of Drug-Resistant TB
Dr. Kevin Fennelly, UMDNJ-New Jersey Medical School, Newark, NJ, USA
Afternoon Session
Evidence Base for Policy Decisions Regarding Tuberculosis Diagnostics
Dr. Madhukar Pai, McGill University, Montreal, QC, Canada
Scheme for Identification of Mycobacteria in a Hospital Laboratory
Dr. Niaz Banaei, Stanford University, Stanford, CA, USA
Faulty Laboratory Results: When to Suspect and How to Resolve
Ms. Grace Lin, California Department of Public Health, Richmond, CA, USA
Mycobacteriology Capabilities in Asian Countries: How This Impacts TB in Immigrants to North America
Dr. Ed Desmond, California Department of Public Health, Richmond, CA, USA
FEBRUARY 28, 2009:
Morning Session
The Role of Re-Infection in TB Pathogenesis
Dr. David N. McMurray, Texas A&M University, College Station, TX, USA
Laboratory Approaches to Drug Development
Dr. Eric Rubin, Harvard School of Public Health, Boston, MA, USA
Afternoon Session
IGRA Use in Children: What Do We Know and Where Do We Go?
Dr. Anna Mandalakas, Case Western Reserve University, Cleveland, OH, USA
Impact of Foreign Born Children with LTBI
Dr. Stacene Maroushek, Hennepin County Medical Center/University of Minnesota, Minneapolis, MN, USA
Pediatric Tuberculosis - Hot Topics/Unresolved Issues in Clinical Practice
Dr. Ann Loeffler, Legacy Emmanuel Children’s Hospital, Portland, OR, USA
Involving Children in TB Drug Development: Past, Present, and Future
Dr. William Burman, Denver Public Health, Denver, CO, USA
